Results 111 to 120 of about 214 (122)

Clinical, Etiologic, and Histopathologic Features of Stevens-Johnson Syndrome During an 8-Year Period at Mayo Clinic

Mayo Clinic Proceedings, 2010
Michael Camilleri, David Wetter
exaly  

UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

Journal of Plastic, Reconstructive and Aesthetic Surgery, 2016
Catherine Smith, Jane Setterfield, Christopher Bunker   +2 more
exaly  

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Clinical Reviews in Allergy and Immunology, 2017
Benedetta Terziroli Beretta-Piccoli, Marianne Lerch, Terziroli Beretta-Piccoli Benedetta   +2 more
exaly  

Vaginal Adhesions Caused by Stevens-Johnson Syndrome

Journal of Pediatric and Adolescent Gynecology, 2002
Sarah Creighton
exaly  

Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Journal of Investigative Dermatology, 2017
Shuen-Iu Hung, TERESA Bellon, Shih-Chi Su   +2 more
exaly  

Stevens-Johnson syndrome

Journal of Emergency Medicine, 1984
OSCAR E Araujo, Franklin P Flowers
exaly  

Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease which Differs from Erythema Multiforme

Journal of Dermatology, 1997
J C Roujeau
exaly  

Corticosteroids in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Annals of Pharmacotherapy, 2015
Ernest H Law
exaly  

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention

American Journal of Medicine, 2016
Sheena Sikora, Mark G Kirchhof, Anthony Papp   +2 more
exaly  

Carbamazepine, HLA-B*1502 and Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: US FDA Recommendations

Pharmacogenomics, 2008
Howard Mcleod, P Brent Ferrell
exaly